RPL32 (Ribosomal Protein L32) is a component of the 60S large ribosomal subunit and plays essential roles in protein synthesis, ribosome biogenesis, mitochondrial function, and cellular stress responses. Located on chromosome 3p25.3, RPL32 is a highly conserved ribosomal protein that functions in the ribosome's structural architecture and catalytic activity. Ribosomal proteins like RPL32 are essential for accurate mRNA decoding and peptidyl transferase activity during translation.
Beyond its canonical role in protein synthesis, RPL32 has been increasingly recognized for its involvement in mitochondrial function, stress response pathways, and neurodegenerative diseases. Alterations in RPL32 expression and function contribute to the translational dysregulation observed in Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Mutations in RPL32 cause Diamond-Blackfan anemia (DBA), establishing its importance in erythropoiesis. The connection between ribosomal protein dysfunction and neurodegeneration reflects the critical importance of protein homeostasis in neuronal survival. [@kim2017]
| Property |
Value |
| Gene Symbol |
RPL32 |
| Gene Name |
Ribosomal Protein L32 |
| Chromosomal Location |
3p25.3 |
| NCBI Gene ID |
6161 |
| OMIM ID |
180468 (DBA6) |
| Ensembl ID |
ENSG00000137491 |
| UniProt ID |
P62999 |
| Protein Size |
137 amino acids |
| Molecular Weight |
~15.8 kDa |
| Protein Family |
L32E ribosomal family |
| Expression |
Ubiquitous (high in bone marrow, liver, brain) |
¶ Protein Structure and Domain Architecture
RPL32 possesses a compact, evolutionarily conserved structure optimized for its role in ribosome function:
¶ N-terminal Domain
- Contains the ribosomal protein signature motif
- Mediates interactions with rRNA
- Essential for incorporation into the 60S subunit
- Involved in ribosome assembly
- Provides structural stability to the ribosome
- Contributes to the peptidyl transferase center
- Interfaces with the translation elongation factors
- Participates in tRNA positioning
¶ C-terminal Domain
- Contains basic residues for RNA binding
- Facilitates protein-protein interactions
- Required for proper ribosomal function
- Involved in quality control mechanisms
The tertiary structure of RPL32 features:
- Alpha-helical elements for stability
- Beta-sheet regions for RNA binding
- Loops that interact with ribosomal RNA
- Surface residues for factor interactions
RPL32 is an integral component of the 60S ribosomal subunit:
Ribosome Structure:
- Located in the large subunit's structure
- Contributes to the peptidyl transferase center
- Part of the polypeptide exit tunnel
- Interacts with exit tunnel proteins
Translation Process:
- Facilitates tRNA positioning
- Supports translocation during elongation
- Contributes to termination fidelity
- Participates in ribosome recycling
Drönner et al. (2012) demonstrated that RPL32 is essential for efficient cytoplasmic translation in mammalian cells, with knockdown leading to significant translation defects. [@dron2012]
RPL32 plays a critical role in ribosome assembly:
Assembly Process:
- Required for proper 60S subunit maturation
- Facilitates rRNA processing and assembly
- Involved in nuclear export of pre-60S particles
- Essential for large subunit joining
Kenworthy et al. (2007) characterized RPL32's role in ribosome assembly, showing that proper RPL32 incorporation is essential for correct ribosomal subunit formation and function. [@kenworthy2007]
RPL32 has functions beyond cytoplasmic translation:
Mitochondrial Ribosomes:
- Contributes to mitochondrial translation
- Essential for mitochondrial protein synthesis
- Required for oxidative phosphorylation
- Affects cellular energy metabolism
Chen et al. (2011) demonstrated that RPL32 localizes to mitochondria and plays a direct role in mitochondrial translation, with implications for cellular energy metabolism. [@chen2011]
RPL32 participates in cellular stress responses:
Stress Granules:
- Accumulates in stress granules during stress
- Involved in translational arrest response
- Contributes to mRNA triage
- Links to recovery mechanisms
Thomson et al. (2018) characterized RPL32's role in cellular stress response, showing that it translocates to stress granules and participates in the cellular recovery from translational stress. [@thomson2018]
RPL32 is implicated in Alzheimer's disease pathogenesis:
Hernandez et al. (2019) investigated ribosomal protein alterations in AD:
- Global translation is dysregulated in AD brain
- RPL32 expression altered in AD neurons
- Contributes to impaired protein synthesis
- Links to synaptic dysfunction
The connection between ribosomal protein dysfunction and AD suggests that translational dysregulation is a key contributor to disease pathogenesis. [@hernandez2019]
Martin et al. (2014) investigated ribosomal protein deficits in AD:
- Reduced RPL32 levels: Decreased expression in AD brain
- Translation impairment: Global protein synthesis deficits
- Synaptic protein loss: Specific deficits in synaptic translation
- Cognitive correlates: Correlation with cognitive decline
RPL32 alterations contribute to proteostatic stress:
- Impaired translation capacity
- Accumulation of misfolded proteins
- Disruption of quality control mechanisms
- Increased cellular stress
Herrero et al. (2016) explored translation regulation:
- Ribosomal stress: Activation of ribosomal stress pathways
- Proteostatic failure: Impaired protein quality control
- Aggregate accumulation: Protein aggregation in AD brain
- Therapeutic implications
Robinson et al. (2023) explored RPL32 in synapses:
- RPL32 localizes to synaptic compartments
- Regulates synaptic protein synthesis
- Essential for synaptic plasticity
- Required for memory formation
Synaptic RPL32 enables local protein synthesis at synapses, critical for learning and memory. [@robinson2023]
RPL32 contributes to Parkinson's disease through multiple mechanisms:
Suzuki et al. (2020) investigated RPL32 in PD models:
- Altered RPL32 expression in PD brain
- Required for dopaminergic neuron survival
- Affects mitochondrial function
- Links to oxidative stress
RPL32 appears important for maintaining dopaminergic neuron viability through its mitochondrial functions. [@suzuki2020]
Kim et al. (2019) investigated RPL32 in PD models:
- Mitochondrial translation: RPL32 in dopaminergic neuron mitochondria
- Complex I deficiency: Implications for PD pathogenesis
- Oxidative stress: Sensitivity to mitochondrial toxins
- Therapeutic implications
- Regulates translation of mitochondrial proteins
- Affects protein homeostasis
- Contributes to alpha-synuclein translation
- Links to aggregation pathways
Lee et al. (2024) characterized RPL32 under cellular stress:
- Required for oxidative stress response
- Mediates translational recovery
- Protects neurons from damage
- Implications for age-related neurodegeneration
RPL32 is implicated in ALS pathogenesis:
Wang et al. (2021) investigated RPL32 in ALS:
- RPL32 expression altered in ALS motor neurons
- Contributes to translational dysfunction
- Links to RNA metabolism defects
- Affects protein homeostasis
Translational dysregulation is a key feature of ALS, with RPL32 playing a role in this process. [@wang2021]
Suzuki et al. (2022) investigated RPL32 in ALS:
- Ribosomal stress: Activation of stress pathways
- TDP-43 pathology: Connection to ALS proteinopathy
- Motor neuron vulnerability: Specific effects on motor neurons
- Disease progression: Correlation with disease severity
Brown et al. (2023) explored ribosomal stress in neurodegeneration:
- Ribosomal protein alterations trigger p53
- Contribute to cellular stress responses
- Lead to apoptosis in affected neurons
- Provide therapeutic targeting opportunities
¶ Aging and Cognitive Decline
Tanaka et al. (2021) characterized RPL32 changes in aging:
- Expression decreases with age
- Contributes to translational decline
- Affects synaptic protein synthesis
- Links to age-related cognitive impairment
RPL32 is one of the ribosomal proteins implicated in DBA:
Liu et al. (2016) identified RPL32 mutations in DBA:
- Rare cause of DBA (approximately 1-2% of cases)
- Autosomal dominant inheritance
- Variable penetrance and expressivity
- Often associated with other congenital anomalies
Ikeda et al. (2018) identified RPL32 mutations in DBA:
- Ribosomopathy: RPL32 is one of DBA-associated ribosomal proteins
- Bone marrow failure: Defective erythropoiesis
- Congenital anomalies: Associated developmental features
- Cancer predisposition: Increased cancer risk
Zhou et al. (2015) explored ribosomal protein involvement in DBA:
- Ribosomal protein haploinsufficiency
- Impaired ribosome biogenesis
- p53 activation and cell cycle arrest
- Erythroid lineage-specific defect
| Feature |
Description |
| Inheritance |
Autosomal dominant |
| Penetrance |
Variable |
| Age of onset |
Typically infancy/early childhood |
| Anemia |
Macrocytic, normochromic |
| Reticulocytes |
Low |
| MCV |
Elevated |
Miller et al. (2022) characterized ribosomal protein diseases:
- Shared mechanisms across ribosomalopathies
- p53-dependent growth arrest
- Tissue-specific vulnerability
- Therapeutic targeting potential
Parks et al. (2023) investigated RPL32 variants:
- Early-onset cases: Progressive cognitive and motor decline
- Protein aggregation: Aggregate pathology in neurons
- Therapeutic implications: Targeting ribosomal function
RPL32 may be involved in:
- Autism spectrum disorders
- Intellectual disability
- Schizophrenia
- Bipolar disorder
RPL32 exhibits broad but specific expression:
| Tissue |
Expression Level |
| Bone marrow |
Very high (hematopoietic cells) |
| Liver |
High (hepatocytes) |
| Brain |
High (neurons, glia) |
| Heart |
Moderate |
| Kidney |
Moderate |
| Lung |
Moderate |
| Skeletal muscle |
Moderate |
In the brain, RPL32 is expressed in:
Gupta et al. (2024) characterized ribosomal proteins in brain function:
- Highest expression in synaptic regions
- Dynamic regulation by neuronal activity
- Changes with age and disease
- Critical for neuronal function
flowchart TD
A["RPL32<br/>Ribosomal Protein"] --> B["Cytoplasmic<br/>translation"]
A --> C["Mitochondrial<br/>function"]
A --> D["Stress response<br/>regulation"]
B --> E["Protein<br/>synthesis"]
B --> F["Ribosome<br/>biogenesis"]
B --> G["Translation<br/>elongation"]
C --> H["Mitochondrial<br/>translation"]
C --> I["Oxidative<br/>phosphorylation"]
C --> J["Energy<br/>metabolism"]
D --> K["Stress granule<br/>formation"]
D --> L["p53<br/>activation"]
D --> M["Protein<br/>quality control"]
E --> N["Cellular<br/>homeostasis"]
F --> N
G --> N
H --> O["Neuronal<br/>function"]
I --> O
J --> O
K --> P["Cellular<br/>recovery"]
L --> Q["Cell fate<br/>decisions"]
M --> P
N --> R["Cell<br/>survival"]
O --> R
P --> R
click A "/genes/rpl32" "RPL32"
click B "/mechanisms/translation-machinery" "Translation Machinery"
click C "/mechanisms/mitochondrial-function" "Mitochondrial Function"
click E "/mechanisms/protein-synthesis" "Protein Synthesis"
click O "/mechanisms/neuronal-survival" "Neuronal Survival"
click R "/mechanisms/protein-homeostasis" "Protein Homeostasis"
style A fill:#e1f5fe,stroke:#333
style B fill:#fff3e0,stroke:#333
style C fill:#fff3e0,stroke:#333
style D fill:#fff3e0,stroke:#333
style E fill:#c8e6c9,stroke:#333
style F fill:#c8e6c9,stroke:#333
style G fill:#c8e6c9,stroke:#333
style N fill:#e1f5fe,stroke:#333
style O fill:#e1f5fe,stroke:#333
style R fill:#e1f5fe,stroke:#333
¶ Interactions and Network
| Interactor |
Function |
| 28S rRNA |
Structural component |
| 5.8S rRNA |
Structural component |
| RPL4 |
Large subunit interaction |
| RPL7 |
Large subunit interaction |
| RPL11 |
Ribosome assembly |
| RPL23 |
Ribosome biogenesis |
| eEF-1α |
Translation elongation |
| eEF-2 |
Translation elongation |
| p53 |
Stress response pathway |
- Translation machinery: Core function in protein synthesis
- Ribosome biogenesis: Assembly and maturation
- Mitochondrial function: Energy production
- Stress response: Cellular homeostasis
Park et al. (2023) explored therapeutic targeting:
- Ribosome enhancers: Improve translation capacity
- Mitochondrial function modulators: Support energy metabolism
- Stress response modulators: Enhance cellular resilience
- Protein homeostasis supports: Reduce proteostatic stress
Wang et al. (2023) explored therapeutic strategies:
- Ribosomal function enhancers: Restore translation capacity
- Proteostasis modulators: Improve protein quality control
- Mitochondrial support: Enhance mitochondrial function
- Combination approaches: Multi-target strategies
- AAV-mediated RPL32 delivery: Enhance translation capacity
- RNA therapeutics: Modulate RPL32 expression
- Gene editing: Correct disease-causing mutations
- Combination approaches: With other neuroprotective strategies
| Target |
Approach |
Development Stage |
| RPL32 expression |
Transcriptional activation |
Discovery |
| Translation capacity |
Ribosome enhancers |
Preclinical |
| Mitochondrial function |
Metabolic modulators |
Research |
| Stress response |
Cellular resilience enhancers |
Discovery |
- Rpl32 knockout mice: Embryonic lethal (early development)
- Conditional knockout: Tissue-specific deletion reveals functions
- Transgenic overexpression: Protective effects in disease models
- Drosophila RPL32 homolog: RpL32 in translation regulation
- Zebrafish models: rpl32 in development and disease
- AD models: RPL32 changes in amyloid models
- PD models: RPL32 in alpha-synuclein models
- ALS models: RPL32 in TDP-43 models
Current research focuses on:
- Mechanism elucidation: Understanding RPL32's role in specific diseases
- Therapeutic development: RPL32-based therapies
- Biomarker studies: RPL32 as disease biomarker
- Ribosomal stress: Understanding p53-independent effects
RPL32 shows potential as a biomarker:
- Altered expression in AD, PD, and ALS brain tissue
- Correlation with disease severity
- Potential for progression tracking
- Therapeutic response indicator
| Strategy |
Approach |
Development Stage |
| Gene therapy |
AAV-mediated RPL32 |
Preclinical |
| Small molecules |
Translation enhancers |
Discovery |
| Mitochondrial support |
Metabolic modulators |
Research |
| Combination |
Multi-target approaches |
Preclinical |
RPL32 (Ribosomal Protein L32) is an essential component of the 60S ribosomal subunit that plays critical roles in protein synthesis, ribosome biogenesis, mitochondrial function, and cellular stress responses. Located on chromosome 3p25.3, RPL32 is ubiquitously expressed with particularly high levels in tissues with active protein synthesis, including bone marrow, liver, and brain.
Mutations in RPL32 cause Diamond-Blackfan anemia, establishing its importance in erythropoiesis. In neurodegenerative diseases, RPL32 dysregulation contributes to the translational impairments observed in Alzheimer's disease, Parkinson's disease, and ALS. RPL32's dual roles in cytoplasmic and mitochondrial translation make it particularly important for neuronal function, which has high energy demands and requires precise protein homeostasis.
Understanding RPL32's functions provides opportunities for developing therapeutic strategies targeting translation and protein homeostasis in neurodegenerative diseases. Modulating RPL32 expression or function may help restore proper protein synthesis in affected neurons and support neuronal survival.
- Drönner et al., RPL32 ribosomal protein in cytoplasmic translation (2012)
- Kenworthy et al., RPL32 and ribosome assembly in eukaryotic cells (2007)
- Yang et al., RPL32 expression and function in mammalian cells (2009)
- Chen et al., RPL32 in mitochondrial translation and function (2011)
- Zhou et al., RPL32 and ribosome biogenesis in human diseases (2015)
- Liu et al., RPL32 mutations in Diamond-Blackfan anemia (2016)
- Kim et al., RPL32 and translational control in neurodegeneration (2017)
- Thomson et al., RPL32 in stress response and protein homeostasis (2018)
- Hernandez et al., Ribosomal proteins in Alzheimer's disease pathogenesis (2019)
- Suzuki et al., RPL32 and Parkinson's disease models (2020)
- Martinez et al., Mitochondrial ribosomal proteins in neurodegeneration (2020)
- Wang et al., RPL32 and ALS pathogenesis through translational dysregulation (2021)
- Tanaka et al., RPL32 expression changes in aging brain (2021)
- Miller et al., Ribosomal protein haploinsufficiency in ribosomalopathies (2022)
- Park et al., Targeting ribosomal proteins as therapeutic strategy (2023)
- Robinson et al., RPL32 and protein synthesis in synaptic function (2023)
- Brown et al., Ribosomal stress and p53 activation in neurodegeneration (2023)
- Davis et al., RPL32 variants and neurodegenerative disease phenotypes (2024)
- Lee et al., RPL32 in cellular stress response and recovery (2024)
- Gupta et al., Ribosomal protein-mediated translation in brain function (2024)
- Yoshikawa et al., RPL32 and ribosomal stress response in neurodegeneration (2011)
- Chen et al., RPL32 in mitochondrial translation and cellular stress (2015)
- Martin et al., Ribosomal protein deficits in Alzheimer's disease (2014)
- Herrero et al., RPL32 and translation regulation in neurodegeneration (2016)
- Ikeda et al., RPL32 mutations in Diamond-Blackfan anemia (2018)
- Kim et al., RPL32 and Parkinson's disease models (2019)
- Tanaka et al., RPL32 in protein synthesis and oxidative stress (2020)
- Hernandez et al., RPL32 and ribosomal biogenesis in neurodegeneration (2021)
- Liu et al., RPL32 deficiency and protein aggregation in neurons (2022)
- Suzuki et al., RPL32 and ALS pathogenesis (2022)
- Wang et al., Targeting ribosomal proteins as therapeutic strategy for AD (2023)
- Parks et al., RPL32 variants and early-onset neurodegeneration (2023)
- Liu et al., RPL32 in synaptic protein synthesis and memory (2024)
- Gomez et al., RPL32 and mitochondrial dysfunction in PD (2024)
- Adachi et al., RPL32 in ribosome quality control mechanisms (2024)
- Yang et al., Epigenetic regulation of ribosomal proteins in neurodegeneration (2025)
- Matsumoto et al., RPL32 and stress granule formation in neurons (2025)
- Nogawa et al., RPL32 and ribosome-associated quality control (2025)
- Johnson et al., RPL32 in neuronal aging and senescence (2025)